SEE.D Trademark

Trademark Overview


On Wednesday, December 15, 2021, a trademark application was filed for SEE.D with the United States Patent and Trademark Office. The USPTO has given the SEE.D trademark a serial number of 79332683. The federal status of this trademark filing is REGISTERED as of Tuesday, January 30, 2024. This trademark is owned by TETHIS S.P.A.. The SEE.D trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Medical Instrument Products categories with the following description:

Scientific, measuring apparatus and instruments namely system for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets; laboratory testing equipment, namely, glass slides, laboratory vials, test tubes, flasks for laboratory use, pipettor tips for laboratory use, racks, namely, vial racks, tip racks, slide racks, and reagent racks for laboratory use; diagnostic apparatus for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets for laboratory or research use; instruments for processing blood samples, namely, system for body fluids processing, glass slides, laboratory vials, test tubes, flasks for laboratory use, pipettor tips for laboratory use, racks, namely, vial racks, tip racks, slide racks, and reagent racks; laboratory aut...

Surgical and medical apparatus and instruments, namely, apparatus and instruments for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets; testing equipment, namely, blood testing apparatus; diagnostic apparatus, namely, diagnostic apparatus for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets for diagnostic and medical purposes; instruments for processing blood samples, namely, apparatus for blood analysis; automatic robot systems, namely, medical robots for processing biological samples and managing reagents on carrier, namely, medical robots for blood lysis protocols, medical robots for plasma extraction, medical robots for preparation of samples for cytological analysis, for nucleic acid extraction, for extracellular ...
see.d

General Information


Serial Number79332683
Word MarkSEE.D
Filing DateWednesday, December 15, 2021
Status700 - REGISTERED
Status DateTuesday, January 30, 2024
Registration Number7292227
Registration DateTuesday, January 30, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "SEE.D" in lowercase and design. The letters "SEE" appear in blue in a large font. A blue dot appears within the curve of the second letter "E". The letter "D" appears in light blue and the loop of the letter "D" partially overlaps the curve of the second letter "E". The overlap of the letters with the dot in the center forms an eye.
Goods and ServicesScientific, measuring apparatus and instruments namely system for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets; laboratory testing equipment, namely, glass slides, laboratory vials, test tubes, flasks for laboratory use, pipettor tips for laboratory use, racks, namely, vial racks, tip racks, slide racks, and reagent racks for laboratory use; diagnostic apparatus for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets for laboratory or research use; instruments for processing blood samples, namely, system for body fluids processing, glass slides, laboratory vials, test tubes, flasks for laboratory use, pipettor tips for laboratory use, racks, namely, vial racks, tip racks, slide racks, and reagent racks; laboratory automatic robotic systems for processing biological samples and managing reagents on carrier; instruments for managing biological samples in relation to diagnostics and oncology fields, namely laboratory instruments for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets for research or laboratory use in diagnostic and oncology fields; parts and fittings for all the aforesaid goods and the aforesaid goods in particular for laboratory diagnostic and research use
Description of the Colors ClaimedSEE and dot in blue; D in light blue.
Indication of Colors claimedThe color(s) blue and light blue is/are claimed as a feature of the mark.
Goods and ServicesSurgical and medical apparatus and instruments, namely, apparatus and instruments for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets; testing equipment, namely, blood testing apparatus; diagnostic apparatus, namely, diagnostic apparatus for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets for diagnostic and medical purposes; instruments for processing blood samples, namely, apparatus for blood analysis; automatic robot systems, namely, medical robots for processing biological samples and managing reagents on carrier, namely, medical robots for blood lysis protocols, medical robots for plasma extraction, medical robots for preparation of samples for cytological analysis, for nucleic acid extraction, for extracellular component analysis; instruments for managing biological samples, in particular for diagnosis including in oncology field, namely, medical instruments for body fluids processing for application in preparation for examination of liquid and corpuscular part, namely, cells, exosomes, nucleic acids, proteins, vesicles, metabolites, platelets for diagnostic and medical purposes in the oncology fields; parts and fittings for all the aforesaid goods

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, February 7, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 7, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTETHIS S.P.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameTETHIS S.P.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameTETHIS S.P.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressIT

Trademark Events


Event DateEvent Description
Friday, February 11, 2022APPLICATION FILING RECEIPT MAILED
Thursday, February 3, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 21, 2022ASSIGNED TO EXAMINER
Thursday, September 29, 2022NON-FINAL ACTION WRITTEN
Friday, September 30, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 13, 2022REFUSAL PROCESSED BY MPU
Tuesday, December 13, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 4, 2023REFUSAL PROCESSED BY IB
Tuesday, June 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, July 8, 2023FINAL REFUSAL WRITTEN
Saturday, July 8, 2023FINAL REFUSAL E-MAILED
Saturday, July 8, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, October 6, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, October 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 25, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, November 12, 2023NOTIFICATION PROCESSED BY IB
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 30, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, May 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 2, 2024FINAL DISPOSITION PROCESSED
Monday, May 27, 2024FINAL DECISION TRANSACTION PROCESSED BY IB